The demonstration that potentially-protective anti-PrP antibodies were detected in some individuals without obvious signs of neurotoxicity raises hope that antibody-based intervention strategies against prion diseases may be tolerated without significant adverse reactions. This evidence concerns the gene PRNP and prion disease.